CSL Seqirus

Focus: CSL Seqirus is a UK-based biotechnology company specializing in flu vaccines and a diversified pipeline spanning infectious diseases, immunology, and hematology. The company operates as a subsidiary within the broader CSL Limited ecosystem with 119 active job openings.

Infectious Diseases Vaccines

Profile data last refreshed 12h ago · AI intelligence enriched 2w ago

Open Jobs

181-33 this month

Contracting — net -33 jobs in 30d

125 added, 158 removed. Active reduction in progress.

Should You Work at CSL Seqirus?

AI assessment

CSL Seqirus offers meaningful career opportunities in specialty pharma with broad pipeline exposure, but lack of financial transparency and unknown funding status create uncertainty around long-term job security.

Why Work Here

Diversified pipeline of 30 programs across vaccines, immunoglobulins, and rare blood disorders provides exposure to multiple therapeutic modalities and disease areas

Data completeness

2/9 — Limited

Company HealthSolid

Pipeline

Early-stage

50 total

LOE Risk

Protected

No near-term cliffs

Hiring

Stable

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Immunological diagnosis tests

Complement Deficiency

N/A

Clinical Trials (1)

NCT02972281Systematic Search for Primary Immunodeficiency in Adults With Infections

N/A

Help build intelligence for CSL Seqirus

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Active hiring across 119 roles, with strong emphasis on Commercial (22), R&D (16), and Regulatory Affairs (14), indicating growth and expansion phase

Established position in high-stakes therapeutic areas (hemophilia, hereditary angioedema, immunodeficiency) with multiple Phase 3/4 programs approaching regulatory milestones

Watch Out For

No publicly available financial data, revenue figures, or R&D spend prevents assessment of cash runway, investment capacity, or long-term stability
Pipeline appears acquisition-heavy with programs inherited from multiple origins; limited transparency on internal innovation velocity or success rates

Generated by Claude from CSL Seqirus's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

FCH

Congenital Fibrinogen Deficiency

N/A

Clinical Trials (1)

NCT02427217An Observational Cohort Study of the Safety and Efficacy of Fibrinogen Concentrate, Human (FCH) in Subjects With Congenital Fibrinogen Deficiency

N/A

CSL830

Various

N/A

Clinical Trials (1)

NCT03177005Expanded Access for Hereditary Angioedema (HAE)

N/A

National Study of Moderate and Severe Von Willebrand Disease in the Netherlands

Von Willebrand Disease

N/A

Clinical Trials (1)

NCT00510042National Study of Moderate and Severe Von Willebrand Disease in the Netherlands

N/A

Safety and Effectiveness of a Patient Blood Management (PBM) Program in Surgical Patients

Surgery

N/A

Clinical Trials (1)

NCT01820949Safety and Effectiveness of a Patient Blood Management (PBM) Program in Surgical Patients

N/A

ATHN 8: Previously Untreated Patients (PUPs) Matter Study

Hemophilia

N/A

Clinical Trials (1)

NCT03818529ATHN 8: Previously Untreated Patients (PUPs) Matter Study

N/A

Beriplex® P/N

Coagulation Protein Disorders

N/A

Clinical Trials (1)

NCT01053169Observational Study of Prophylaxis and Treatment of Acute Perioperative Bleeding With Beriplex® P/N (Probe Study)

N/A

mgt of bleeding concerns/complications of oral anticoagulants

Blood Coagulation

N/A

Clinical Trials (1)

NCT02745054Safety of Oral Anticoagulants Registry

N/A

Precision Medicine in Cardiovascular Surgery Associated Acute Kidney Injury

Acute Kidney Injury

N/A

Clinical Trials (1)

NCT06471621Precision Medicine in Cardiovascular Surgery Associated Acute Kidney Injury

N/A

questionnaire survey

Immune Deficiency, Antibody

N/A

Clinical Trials (1)

NCT02542228Construction of a Health-related Quality of Life (HR-QOL) Questionnaire for Patients With Primary Antibody Deficiency Disease

N/A

Quality of Life Study of Helixate NexGen

Hemophilia A

N/A

Clinical Trials (1)

NCT01053715Quality of Life Study of Helixate NexGen

N/A

Kcentra®

Hemorrhage

N/A

Clinical Trials (1)

NCT02319460An Observational Cohort Study to Investigate the Risk of Thromboembolic Events in Patients Receiving Kcentra® or Plasma to Reverse Vitamin K Antagonist (VKA) Therapy in the Setting of Acute Major Bleeding

N/A

Respreeza® Self-administration and Learning Program (AmAREtTI Study)

Alpha-1 Antitrypsin Deficiency

N/A

Clinical Trials (1)

NCT04262284Respreeza® Self-administration and Learning Program (AmAREtTI Study)

N/A

VWF/FVIII concentrates

Severe Hemophilia A

N/A

Clinical Trials (1)

NCT01051076Rescue Immunotolerance Study in Induction of Immune Tolerance (ITI)-Experienced Patients (RES.I.S.T. Experienced)

N/A

SQ IVIG

Infections After Lung Transplant

N/A

Clinical Trials (1)

NCT01361178Immunoglobulin Levels and Occurrence of Infections After Lung Transplantation and Impact of IgG Replacement

N/A

Berinert®

Includes: Hereditary Angioedema

N/A

Clinical Trials (1)

NCT01108848Patient Registry Study of Berinert® in Normal Clinical Practice

N/A

Fibrogammin P

Hemophilia

N/A

Clinical Trials (1)

NCT00640289Clinical Trial of Factor XIII (FXIII) Concentrate

N/A

No intervention

Hereditary Angioedemas

N/A

Clinical Trials (1)

NCT07001280A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE)

N/A

Chronic active AMR group

Antibody-mediated Rejection in Kidney Transplant

N/A

Clinical Trials (1)

NCT05452317Assess Burden of Disease Among Kidney Transplant Recipients With Chronic Active Antibody Mediated Rejection

N/A

ROTEM analysis

Aneurysmatic Subarachnoid Haemorrhage

N/A

Clinical Trials (1)

NCT02540005Coagulation Disorders After Aneurysmatic Subarachnoid Haemorrhage

N/A

VWF/FVIII products

Von Willebrand Disease

N/A

Clinical Trials (1)

NCT00557908The Von Willebrand Disease (VWD) International Prophylaxis Study

N/A

AAV5-hFIXco-Padua

Hemophilia B

N/A

Clinical Trials (1)

NCT05962398Long-term Follow-up Study of Male Adults With Hemophilia B Previously Treated With Etranacogene Dezaparvovec (CSL222)

N/A

Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013

Hemophilia

N/A

Clinical Trials (1)

NCT02546622ATHN 2: Factor Switching Study

N/A

Subcutaneous IgG

Primary Immune Deficiency

N/A

Clinical Trials (1)

NCT01166074Retrospective Chart Review of Subcutaneous IgG Use in Infants

N/A

Additional blood sampling at the same time and in addition of samplings already done for the patient's standard of care.

Liver Cirrhosis

N/A

Clinical Trials (1)

NCT06050993Effects of Platelet Mimicking Nanoparticles in Patients With Cirrhosis

N/A

subcutaneous immunoglobulin

Hypogammaglobulinemia

N/A

Clinical Trials (1)

NCT03401268Subcutaneous Ig in Allogeneic Stem Cell Transplant Recipients

N/A

IVIg

CIDP

N/A

Clinical Trials (1)

NCT05614128Validation of Cutaneous Nerve Demyelination in Diagnosis and Treatment of CIDP

N/A

Immune Globulin Subcutaneous

Chronic Inflammatory Demyelinating Polyneuropathy

N/A

Clinical Trials (1)

NCT02465359Subcutaneous Immunoglobulin for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

N/A

Observatory of Patients With Haemophilia B Treated by IdElvion®

Haemophilia B

N/A

Clinical Trials (1)

NCT05086575Observatory of Patients With Haemophilia B Treated by IdElvion®

N/A

Voncento®

Von Willebrand Disease

N/A

Clinical Trials (1)

NCT04657887Registry of Patients With Von WilLEbrand Disease Treated With Voncento®

N/A

Intravenous Immunoglobulin

Chronic Inflammatory Demyelinating Polyneuropathy

N/A

Clinical Trials (1)

NCT02414490IVIg Treatment-Related Fluctuations in CIDP Patients Using Daily Grip Strength Measurements

N/A

Pulmonary rehabilitation

Chronic Obstructive Pulmonary Disease

N/A

Clinical Trials (1)

NCT02915614Effects of Pulmonary Rehabilitation on Skeletal Muscle in COPD Patients

N/A

CSL312

Hereditary Angioedema (HAE)

N/A

Clinical Trials (1)

NCT07159464Post Study Access of CSL312 (Garadacimab) for Pediatric Participants With Hereditary Angioedema Who Have Completed the CSL312_3003 Study

N/A

Australian and New Zealand Massive Transfusion Registry

Massive Transfusion

N/A

Clinical Trials (1)

NCT02863250Australian and New Zealand Massive Transfusion Registry

N/A

HOME LINK

Chronic Inflammatory Demyelinating Polyneuropathy

N/A

Clinical Trials (1)

NCT03779828Evaluating the Effectiveness of Telemonitoring System in the Management of Patients With CIDP

N/A

Vitamin D and calcium

Hemophilia A

N/A

Clinical Trials (1)

NCT01090206Correlation Between Vitamin D Status and Bone Mineral Density in Patients With Hemophilia

N/A

The German Patient Blood Management Network

Clinical Safety of a PBM Program

N/A

Clinical Trials (1)

NCT02147795The German Patient Blood Management Network

N/A

FVIII Concentrates

Severe Hemophilia A

N/A

Clinical Trials (1)

NCT01051544Study of First TIME Immunotolerance Induction in Severe Hemophilia A Patients With Inhibitor at High Risk of Failure: Comparison With FVIII Concentrates With or Without Von Willebrand Factor - RES.I.S.T. Naive

N/A

Blood collection

Ataxia Telangiectasia

N/A

Clinical Trials (1)

NCT02345135Susceptibility to Infections in Ataxia Telangiectasia

N/A

Joint Health Study

Hemophilia B

N/A

Clinical Trials (1)

NCT03358836Joint Health Study

N/A

Hizentra

Chronic Inflammatory Demyelinating Polyneuropathy

N/A

Clinical Trials (2)

NCT05193552Usage of Spirometry in Managing IgG Therapy in CVID With Airway Disease

Phase 4

NCT04672733Hizentra® in Inflammatory Neuropathies - pHeNIx Study

N/A

Afstyla®

Haemophilia A

N/A

Clinical Trials (1)

NCT04675541Register of Patients With haEmophilia A tReated With Afstyla®

N/A

HEMGENIX

Hemophilia B

N/A

Clinical Trials (1)

NCT06008938An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B

N/A

Genetic Sequencing

Alpha-1 Antitrypsin Deficiency

N/A

Clinical Trials (1)

NCT02810327Alpha-1 Carrier Genomics Study

N/A

Privigen

Systemic Sclerosis

N/A

Clinical Trials (1)

NCT01785056IVIG Treatment in Systemic Sclerosis

N/A

Von Willebrand Disease in the Netherlands

Von Willebrand Disease

N/A

Clinical Trials (1)

NCT03521583Von Willebrand Disease in the Netherlands

N/A

Data collection on interventions performs as per medical routine

Anemia

N/A

Clinical Trials (1)

NCT06878105Patient Blood Management Implementation in CEE Study

N/A

Rabies Vaccine

Rabies

N/A

Clinical Trials (1)

NCT01063140Rabies Immune Plasma Booster Study

N/A

Health Related Quality of Life of Youth and Young Adults With Hemophilia A

Hemophilia A

N/A

Clinical Trials (1)

NCT01034904Health Related Quality of Life of Youth and Young Adults With Hemophilia A

N/A

gammaglobulin

Common Variable Immunodeficiency

N/A

Clinical Trials (1)

NCT00661401Specific IgG Antibody in Patients With Primary Antibody Deficiencies Treated With Subcutaneous Immunoglobulin

N/A

Interview Prep Quick Facts

Portfolio: 150 clinical trials

Top TAs: Rare Diseases, Neurology, Nephrology

Open Roles: 181 active jobs

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Therapeutic Area Focus

40 pipeline

14 pipeline

10 pipeline

9 pipeline

8 pipeline

7 pipeline

Marketed

Pipeline

Hiring Trend

Actively Hiring

181

Open Roles

+18

Added

-12

Filled/Removed

Based on last 4 crawl cycles

Hematology

2 pipeline

CSL Seqirus

Should You Work at CSL Seqirus?

Why Work Here

Pipeline & Clinical Trials

Watch Out For

Open Jobs (181)

Financial & Statutory Reporting Accountant, Colombia

Center Arzt Mainz (m/w/x)

Principal Scientist, Translational Science Immunology

Associate Director, Research Laboratory Operations

Head of Site Supply Chain

Senior Regional Facilities Manager & Vendor Contract Management

Associate Director, Clinical Trial Disclosure & Transparency

Manager, AI & Advanced Analytics

Director, Agentic Software Development

Associate Director, Regulatory Project Manager

Senior Programmer, EDC Systems

Employee Relations Manager

Director, Regional Ecosystem Lead (Northern Europe & UK)

Sr. Director, Global Brand & Portfolio Management

Director, Project Management Search & Evaluation

Vaccines Safety Sciences Lead

Senior Manager, Clinical Operations - FSP Resource & Vendor Management

Director - Regulatory Platforms

Associate Director (m/f/x), Indirect Procurement

Manager, Regional Regulatory Lead - LCM

Director, Operations Lead - Private-Public Partnership (Tolling)

Medizinische Fachangestellte (MFA), ZFA, Rettungssanitäter, Pflegehelfer etc. (m/w/d) für unser Plasmacenter

Director, Epidemiology

Head of Global Labelling

Senior Director, Head of Medical Evidence Generation

Hiring Trend